Investigational administration Xeomin

Phase 3Small molecule

AAssistance Publique - Hôpitaux de Paris

Investigational administration Xeomin is one of 4 small molecule programs targeting Critical Illness. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Critical IllnessRecruiting

Critical IllnessPhase 3

Recruiting

Competition

Competitive Landscape

3 competitors in Critical Illness

#DrugCompanyPhaseTrials

Decadron

AAspen Global Incorporated

Approved

1 2

Fragmin

Pfizer

Phase 3

1 3

Ketalar

AAultman Health Foundation

Phase 2

1 4

Investigational administration Xeomin

AAssistance Publique - Hôpitaux de Paris

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Erectile Dysfunction1 trial

Efficacy of Intracavernosal as add-on Therapy to Sildenafil 100 mg on Demand Compared to Sildenafil 100 mg on Demand for the Treatment of Erectile Dysfunction (ED) Not Sufficiently Responsive to Standard Therapy With Phosphodiesterase Type 5 Inhibitors

Completed·AAssistance Publique - Hôpitaux de Paris·Phase 2·NCT05196308·226 enrolled

Critical Illness1 trial

Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency

Recruiting·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT04404400·1,092 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Investigational administration Xeomin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Investigational administration Xeomin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Investigational administration Xeomin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: AAssistance Publique - Hôpitaux de Paris

Investigational administration Xeomin

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Erectile Dysfunction1 trial

Critical Illness1 trial

References

Drug Info

Quick Facts

Related News